Practical Clinical Microbiology and Infectious Diseases (eBook, ePUB)
A Hands-On Guide
Redaktion: Gronthoud, Firza Alexander
104,95 €
104,95 €
inkl. MwSt.
Sofort per Download lieferbar
52 °P sammeln
104,95 €
Als Download kaufen
104,95 €
inkl. MwSt.
Sofort per Download lieferbar
52 °P sammeln
Jetzt verschenken
Alle Infos zum eBook verschenken
104,95 €
inkl. MwSt.
Sofort per Download lieferbar
Alle Infos zum eBook verschenken
52 °P sammeln
Practical Clinical Microbiology and Infectious Diseases (eBook, ePUB)
A Hands-On Guide
Redaktion: Gronthoud, Firza Alexander
- Format: ePub
- Merkliste
- Auf die Merkliste
- Bewerten Bewerten
- Teilen
- Produkt teilen
- Produkterinnerung
- Produkterinnerung
Bitte loggen Sie sich zunächst in Ihr Kundenkonto ein oder registrieren Sie sich bei
bücher.de, um das eBook-Abo tolino select nutzen zu können.
Hier können Sie sich einloggen
Hier können Sie sich einloggen
Sie sind bereits eingeloggt. Klicken Sie auf 2. tolino select Abo, um fortzufahren.
Bitte loggen Sie sich zunächst in Ihr Kundenkonto ein oder registrieren Sie sich bei bücher.de, um das eBook-Abo tolino select nutzen zu können.
This book offers practical tips and essential guidance for the clinical microbiologist and healthcare professional to put theoretical knowledge into daily practice. This handbook is intended to support the healthcare professional from interpretation of laboratory results, to consultation and infection control.
- Geräte: eReader
- ohne Kopierschutz
- eBook Hilfe
- Größe: 3.12MB
Andere Kunden interessierten sich auch für
- Practical Clinical Microbiology and Infectious Diseases (eBook, PDF)104,95 €
- J. Keith StruthersClinical Microbiology (eBook, ePUB)45,95 €
- Thomas LockeMicrobiology and Infectious Diseases on the Move (eBook, ePUB)24,95 €
- Atul Bhanu MehtaClinical Haematology (eBook, ePUB)33,95 €
- Darren PattenSingle Best Answers in Surgery (eBook, ePUB)37,95 €
- J. Benton PegnaGet Ahead! Surgery: 250 SBAs for Finals (eBook, ePUB)33,95 €
- David MaleImmunology (eBook, ePUB)21,95 €
-
-
-
This book offers practical tips and essential guidance for the clinical microbiologist and healthcare professional to put theoretical knowledge into daily practice. This handbook is intended to support the healthcare professional from interpretation of laboratory results, to consultation and infection control.
Dieser Download kann aus rechtlichen Gründen nur mit Rechnungsadresse in A, B, BG, CY, CZ, D, DK, EW, E, FIN, F, GR, HR, H, IRL, I, LT, L, LR, M, NL, PL, P, R, S, SLO, SK ausgeliefert werden.
Produktdetails
- Produktdetails
- Verlag: Taylor & Francis
- Seitenzahl: 484
- Erscheinungstermin: 28. September 2020
- Englisch
- ISBN-13: 9781351760041
- Artikelnr.: 60118827
- Verlag: Taylor & Francis
- Seitenzahl: 484
- Erscheinungstermin: 28. September 2020
- Englisch
- ISBN-13: 9781351760041
- Artikelnr.: 60118827
- Herstellerkennzeichnung Die Herstellerinformationen sind derzeit nicht verfügbar.
Firza Alexander Gronthoud, MD, DTM&H, is a Consultant Microbiologist at the Royal Marsden NHS Foundation Trust, United Kingdom.
SECTION I Principles of Infection Management
1.1 Pillars of Infection Management
1.2 Diagnostic Stewardship
1.3 Antimicrobial Stewardship
1.4 Infection Prevention and Control
SECTION II Diagnosis of Infections
2.1 Commensal Flora
2.2 Diagnosing Bacterial Infections
2.3 Diagnosing Viral Infections
2.4 Diagnosing Invasive Fungal Infections
2.5 Diagnosing Parasitic Infections
2.6 Laboratory Detection of beta-Lactam Resistance in Enterobacterales
2.7 Understanding the Antibiogram
2.8 Understanding Microbiology Culture Results
2.9 Understanding Serology
2.10 Understanding Molecular Diagnosis
SECTION III Treatment of Infections
3.1 Basic Principles of Antimicrobial Treatment
3.2 Basic Principles of Antifungal Treatment
3.3 beta-Lactam Allergy
3.4 Antimicrobials in Pregnant Women
3.5 Antimicrobial Agents and Liver Injury
3.6 Antimicrobial Agents and Neurotoxicity
3.7 Antimcrobial Agents and Drug Interactions
3.8 Pharmacokinetic and Pharmacodynamic Considerations
3.9 Source Control
3.10 Antibiotic Treatment Failure
SECTION IV Special Problems
4.1 Acute Streptococcal Pharyngitis
4.2 Animal Bites
4.3 Asymptomatic Bacteriuria
4.4 Atypical Pneumonia
4.5 Bacterial Skin and Soft Tissue Infections
4.6 Bloodstream Infections
4.7 Bordetella pertussis
4.8 Breast Abscess
4.9 Bronchiectasis
4.10 Bronchitis
4.11 Brucellosis
4.12 Candiduria
4.13 Cardiac Implantable Device Infections
4.14 Chlamydia trachomatis
4.15 Cholangitis
4.16 Deep Neck Space Infection
4.17 Empyema
4.18 Encephalitis
4.19 Endocarditis
4.20 Neisseria gonorrhoeae
4.21 Hepatitis A
4.22 Hepatitis B
4.23 Hepatitis C
4.24 Hepatitis E
4.25 Histoplasmosis
4.26 Human Immunodeficiency Virus and Opportunistic Infections
4.27 Infections in Haematopoietic Stem Cell Transplants
4.28 Infections in the ICU
4.29 Infectious Diarrhoea
4.30 Influenza
4.31 Intra-Abdominal Infections
4.32 Invasive Candidiasis
4.33 Invasive Group A Streptococcal Infections
4.34 Invasive Pulmonary Aspergillosis
4.35 Keratitis
4.36 Lung Abscess
4.37 Measles
4.38 Meningitis
4.39 Near-Drowning-Associated Pneumonia
4.40 Neutropaenic Sepsis
4.41 Non-Resolving Pneumonia
4.42 Norovirus
4.43 Onychomycosis
4.44 Osteomyelitis
4.45 Otitis Externa
4.46 Pelvic Inflammatory Disease
4.47 Perianal Abscess
4.48 Pneumocystis jirovecii Pneumonia (PJP) in Patients with a Haematological Malignancy or Solid Organ Transplant
4.49 Pneumonia (CAP, HAP and VAP)
4.50 Post-Exposure Prophylaxis for Healthcare Workers Exposed to Blood-Borne Viruses
4.51 Post-Operative Infections
4.52 Prosthetic Joint Infections
4.53 Protatitis
4.54 Pyomyositis
4.55 Ringworm
4.56 Salmonella Carriage
4.57 Septic Arthritis
4.58 Septic Bursitis
4.59 Splenectomy: From Prophylaxis to Treatment
4.60 The Immunocompromised Patient
4.61 Typhoid Fever
4.62 Urinary Tract Infections
4.63 Uveitis
4.64 Varicella Zoster
SECTION V Difficult-to-Treat Organisms
5.1 AmpC, Extended Spectrum beta-Lactamase and Carbapenemase Producers
5.2 Acinetobacter baumannii
5.3 Achromobacter xylosoxidans
5.4 Pseudomonas aeruginosa
5.5 Stenotrophomonas maltophilia
5.6 Staphylococcus aureus
5.7 Vancomycin-Resistant Enterococci
5.8 Helicobacter pylori
5.9 Clostridioides difficile
5.10 Actinomycosis
5. 11 Nocardia
SECTION VI Appendix
6.1 Syndromic Approach to Infections
6.2 Specimen Collection
6.3 Spectrum of Activity of Antibiotics
6.4 Doses of Common Antimicrobials
6.5 Pathogen-Specific Infection Control Precautions
6.6 Pillars of Infection Control
6.7 Transmission-Based Precautions
1.1 Pillars of Infection Management
1.2 Diagnostic Stewardship
1.3 Antimicrobial Stewardship
1.4 Infection Prevention and Control
SECTION II Diagnosis of Infections
2.1 Commensal Flora
2.2 Diagnosing Bacterial Infections
2.3 Diagnosing Viral Infections
2.4 Diagnosing Invasive Fungal Infections
2.5 Diagnosing Parasitic Infections
2.6 Laboratory Detection of beta-Lactam Resistance in Enterobacterales
2.7 Understanding the Antibiogram
2.8 Understanding Microbiology Culture Results
2.9 Understanding Serology
2.10 Understanding Molecular Diagnosis
SECTION III Treatment of Infections
3.1 Basic Principles of Antimicrobial Treatment
3.2 Basic Principles of Antifungal Treatment
3.3 beta-Lactam Allergy
3.4 Antimicrobials in Pregnant Women
3.5 Antimicrobial Agents and Liver Injury
3.6 Antimicrobial Agents and Neurotoxicity
3.7 Antimcrobial Agents and Drug Interactions
3.8 Pharmacokinetic and Pharmacodynamic Considerations
3.9 Source Control
3.10 Antibiotic Treatment Failure
SECTION IV Special Problems
4.1 Acute Streptococcal Pharyngitis
4.2 Animal Bites
4.3 Asymptomatic Bacteriuria
4.4 Atypical Pneumonia
4.5 Bacterial Skin and Soft Tissue Infections
4.6 Bloodstream Infections
4.7 Bordetella pertussis
4.8 Breast Abscess
4.9 Bronchiectasis
4.10 Bronchitis
4.11 Brucellosis
4.12 Candiduria
4.13 Cardiac Implantable Device Infections
4.14 Chlamydia trachomatis
4.15 Cholangitis
4.16 Deep Neck Space Infection
4.17 Empyema
4.18 Encephalitis
4.19 Endocarditis
4.20 Neisseria gonorrhoeae
4.21 Hepatitis A
4.22 Hepatitis B
4.23 Hepatitis C
4.24 Hepatitis E
4.25 Histoplasmosis
4.26 Human Immunodeficiency Virus and Opportunistic Infections
4.27 Infections in Haematopoietic Stem Cell Transplants
4.28 Infections in the ICU
4.29 Infectious Diarrhoea
4.30 Influenza
4.31 Intra-Abdominal Infections
4.32 Invasive Candidiasis
4.33 Invasive Group A Streptococcal Infections
4.34 Invasive Pulmonary Aspergillosis
4.35 Keratitis
4.36 Lung Abscess
4.37 Measles
4.38 Meningitis
4.39 Near-Drowning-Associated Pneumonia
4.40 Neutropaenic Sepsis
4.41 Non-Resolving Pneumonia
4.42 Norovirus
4.43 Onychomycosis
4.44 Osteomyelitis
4.45 Otitis Externa
4.46 Pelvic Inflammatory Disease
4.47 Perianal Abscess
4.48 Pneumocystis jirovecii Pneumonia (PJP) in Patients with a Haematological Malignancy or Solid Organ Transplant
4.49 Pneumonia (CAP, HAP and VAP)
4.50 Post-Exposure Prophylaxis for Healthcare Workers Exposed to Blood-Borne Viruses
4.51 Post-Operative Infections
4.52 Prosthetic Joint Infections
4.53 Protatitis
4.54 Pyomyositis
4.55 Ringworm
4.56 Salmonella Carriage
4.57 Septic Arthritis
4.58 Septic Bursitis
4.59 Splenectomy: From Prophylaxis to Treatment
4.60 The Immunocompromised Patient
4.61 Typhoid Fever
4.62 Urinary Tract Infections
4.63 Uveitis
4.64 Varicella Zoster
SECTION V Difficult-to-Treat Organisms
5.1 AmpC, Extended Spectrum beta-Lactamase and Carbapenemase Producers
5.2 Acinetobacter baumannii
5.3 Achromobacter xylosoxidans
5.4 Pseudomonas aeruginosa
5.5 Stenotrophomonas maltophilia
5.6 Staphylococcus aureus
5.7 Vancomycin-Resistant Enterococci
5.8 Helicobacter pylori
5.9 Clostridioides difficile
5.10 Actinomycosis
5. 11 Nocardia
SECTION VI Appendix
6.1 Syndromic Approach to Infections
6.2 Specimen Collection
6.3 Spectrum of Activity of Antibiotics
6.4 Doses of Common Antimicrobials
6.5 Pathogen-Specific Infection Control Precautions
6.6 Pillars of Infection Control
6.7 Transmission-Based Precautions
SECTION I Principles of Infection Management
1.1 Pillars of Infection Management
1.2 Diagnostic Stewardship
1.3 Antimicrobial Stewardship
1.4 Infection Prevention and Control
SECTION II Diagnosis of Infections
2.1 Commensal Flora
2.2 Diagnosing Bacterial Infections
2.3 Diagnosing Viral Infections
2.4 Diagnosing Invasive Fungal Infections
2.5 Diagnosing Parasitic Infections
2.6 Laboratory Detection of beta-Lactam Resistance in Enterobacterales
2.7 Understanding the Antibiogram
2.8 Understanding Microbiology Culture Results
2.9 Understanding Serology
2.10 Understanding Molecular Diagnosis
SECTION III Treatment of Infections
3.1 Basic Principles of Antimicrobial Treatment
3.2 Basic Principles of Antifungal Treatment
3.3 beta-Lactam Allergy
3.4 Antimicrobials in Pregnant Women
3.5 Antimicrobial Agents and Liver Injury
3.6 Antimicrobial Agents and Neurotoxicity
3.7 Antimcrobial Agents and Drug Interactions
3.8 Pharmacokinetic and Pharmacodynamic Considerations
3.9 Source Control
3.10 Antibiotic Treatment Failure
SECTION IV Special Problems
4.1 Acute Streptococcal Pharyngitis
4.2 Animal Bites
4.3 Asymptomatic Bacteriuria
4.4 Atypical Pneumonia
4.5 Bacterial Skin and Soft Tissue Infections
4.6 Bloodstream Infections
4.7 Bordetella pertussis
4.8 Breast Abscess
4.9 Bronchiectasis
4.10 Bronchitis
4.11 Brucellosis
4.12 Candiduria
4.13 Cardiac Implantable Device Infections
4.14 Chlamydia trachomatis
4.15 Cholangitis
4.16 Deep Neck Space Infection
4.17 Empyema
4.18 Encephalitis
4.19 Endocarditis
4.20 Neisseria gonorrhoeae
4.21 Hepatitis A
4.22 Hepatitis B
4.23 Hepatitis C
4.24 Hepatitis E
4.25 Histoplasmosis
4.26 Human Immunodeficiency Virus and Opportunistic Infections
4.27 Infections in Haematopoietic Stem Cell Transplants
4.28 Infections in the ICU
4.29 Infectious Diarrhoea
4.30 Influenza
4.31 Intra-Abdominal Infections
4.32 Invasive Candidiasis
4.33 Invasive Group A Streptococcal Infections
4.34 Invasive Pulmonary Aspergillosis
4.35 Keratitis
4.36 Lung Abscess
4.37 Measles
4.38 Meningitis
4.39 Near-Drowning-Associated Pneumonia
4.40 Neutropaenic Sepsis
4.41 Non-Resolving Pneumonia
4.42 Norovirus
4.43 Onychomycosis
4.44 Osteomyelitis
4.45 Otitis Externa
4.46 Pelvic Inflammatory Disease
4.47 Perianal Abscess
4.48 Pneumocystis jirovecii Pneumonia (PJP) in Patients with a Haematological Malignancy or Solid Organ Transplant
4.49 Pneumonia (CAP, HAP and VAP)
4.50 Post-Exposure Prophylaxis for Healthcare Workers Exposed to Blood-Borne Viruses
4.51 Post-Operative Infections
4.52 Prosthetic Joint Infections
4.53 Protatitis
4.54 Pyomyositis
4.55 Ringworm
4.56 Salmonella Carriage
4.57 Septic Arthritis
4.58 Septic Bursitis
4.59 Splenectomy: From Prophylaxis to Treatment
4.60 The Immunocompromised Patient
4.61 Typhoid Fever
4.62 Urinary Tract Infections
4.63 Uveitis
4.64 Varicella Zoster
SECTION V Difficult-to-Treat Organisms
5.1 AmpC, Extended Spectrum beta-Lactamase and Carbapenemase Producers
5.2 Acinetobacter baumannii
5.3 Achromobacter xylosoxidans
5.4 Pseudomonas aeruginosa
5.5 Stenotrophomonas maltophilia
5.6 Staphylococcus aureus
5.7 Vancomycin-Resistant Enterococci
5.8 Helicobacter pylori
5.9 Clostridioides difficile
5.10 Actinomycosis
5. 11 Nocardia
SECTION VI Appendix
6.1 Syndromic Approach to Infections
6.2 Specimen Collection
6.3 Spectrum of Activity of Antibiotics
6.4 Doses of Common Antimicrobials
6.5 Pathogen-Specific Infection Control Precautions
6.6 Pillars of Infection Control
6.7 Transmission-Based Precautions
1.1 Pillars of Infection Management
1.2 Diagnostic Stewardship
1.3 Antimicrobial Stewardship
1.4 Infection Prevention and Control
SECTION II Diagnosis of Infections
2.1 Commensal Flora
2.2 Diagnosing Bacterial Infections
2.3 Diagnosing Viral Infections
2.4 Diagnosing Invasive Fungal Infections
2.5 Diagnosing Parasitic Infections
2.6 Laboratory Detection of beta-Lactam Resistance in Enterobacterales
2.7 Understanding the Antibiogram
2.8 Understanding Microbiology Culture Results
2.9 Understanding Serology
2.10 Understanding Molecular Diagnosis
SECTION III Treatment of Infections
3.1 Basic Principles of Antimicrobial Treatment
3.2 Basic Principles of Antifungal Treatment
3.3 beta-Lactam Allergy
3.4 Antimicrobials in Pregnant Women
3.5 Antimicrobial Agents and Liver Injury
3.6 Antimicrobial Agents and Neurotoxicity
3.7 Antimcrobial Agents and Drug Interactions
3.8 Pharmacokinetic and Pharmacodynamic Considerations
3.9 Source Control
3.10 Antibiotic Treatment Failure
SECTION IV Special Problems
4.1 Acute Streptococcal Pharyngitis
4.2 Animal Bites
4.3 Asymptomatic Bacteriuria
4.4 Atypical Pneumonia
4.5 Bacterial Skin and Soft Tissue Infections
4.6 Bloodstream Infections
4.7 Bordetella pertussis
4.8 Breast Abscess
4.9 Bronchiectasis
4.10 Bronchitis
4.11 Brucellosis
4.12 Candiduria
4.13 Cardiac Implantable Device Infections
4.14 Chlamydia trachomatis
4.15 Cholangitis
4.16 Deep Neck Space Infection
4.17 Empyema
4.18 Encephalitis
4.19 Endocarditis
4.20 Neisseria gonorrhoeae
4.21 Hepatitis A
4.22 Hepatitis B
4.23 Hepatitis C
4.24 Hepatitis E
4.25 Histoplasmosis
4.26 Human Immunodeficiency Virus and Opportunistic Infections
4.27 Infections in Haematopoietic Stem Cell Transplants
4.28 Infections in the ICU
4.29 Infectious Diarrhoea
4.30 Influenza
4.31 Intra-Abdominal Infections
4.32 Invasive Candidiasis
4.33 Invasive Group A Streptococcal Infections
4.34 Invasive Pulmonary Aspergillosis
4.35 Keratitis
4.36 Lung Abscess
4.37 Measles
4.38 Meningitis
4.39 Near-Drowning-Associated Pneumonia
4.40 Neutropaenic Sepsis
4.41 Non-Resolving Pneumonia
4.42 Norovirus
4.43 Onychomycosis
4.44 Osteomyelitis
4.45 Otitis Externa
4.46 Pelvic Inflammatory Disease
4.47 Perianal Abscess
4.48 Pneumocystis jirovecii Pneumonia (PJP) in Patients with a Haematological Malignancy or Solid Organ Transplant
4.49 Pneumonia (CAP, HAP and VAP)
4.50 Post-Exposure Prophylaxis for Healthcare Workers Exposed to Blood-Borne Viruses
4.51 Post-Operative Infections
4.52 Prosthetic Joint Infections
4.53 Protatitis
4.54 Pyomyositis
4.55 Ringworm
4.56 Salmonella Carriage
4.57 Septic Arthritis
4.58 Septic Bursitis
4.59 Splenectomy: From Prophylaxis to Treatment
4.60 The Immunocompromised Patient
4.61 Typhoid Fever
4.62 Urinary Tract Infections
4.63 Uveitis
4.64 Varicella Zoster
SECTION V Difficult-to-Treat Organisms
5.1 AmpC, Extended Spectrum beta-Lactamase and Carbapenemase Producers
5.2 Acinetobacter baumannii
5.3 Achromobacter xylosoxidans
5.4 Pseudomonas aeruginosa
5.5 Stenotrophomonas maltophilia
5.6 Staphylococcus aureus
5.7 Vancomycin-Resistant Enterococci
5.8 Helicobacter pylori
5.9 Clostridioides difficile
5.10 Actinomycosis
5. 11 Nocardia
SECTION VI Appendix
6.1 Syndromic Approach to Infections
6.2 Specimen Collection
6.3 Spectrum of Activity of Antibiotics
6.4 Doses of Common Antimicrobials
6.5 Pathogen-Specific Infection Control Precautions
6.6 Pillars of Infection Control
6.7 Transmission-Based Precautions